Researchers from Jilin University Provide Details of New Studies and Findings in the Area of Vaccines (Incorporation of a TGF-b2-inhibiting oligodeoxynucleotide molecular adjuvant into a tumor cell lysate vaccine to enhance antiglioma immunity ...)